Join NexChange - the professional
network for the financial services
industry - and receive a free one-
year subscription to Forbes
Andrew Left Goes Long Fitbit, Sees 130% Upside
Capital Markets, FinTech
Fitbit Inc (NYSE: FIT) was already on the rise Monday when Citron Research came out with a bullish report touting Fitbit as one of the best medtech companies in the industry and forecasting 130-percent upside.
“What was once a piñata for short-sellers (since IPO) has transformed itself to one of the most underappreciated med-tech stories in the market with a balance sheet and brand equity that gives investors a tremendous investing opportunity,” Citron’s Andrew Left wrote in a report.
Left predicted Fitbit will either strike $15 or be …